logo
CDC adjusts COVID vaccine guidance, but keeps on child schedule

CDC adjusts COVID vaccine guidance, but keeps on child schedule

The Hill3 days ago

The Centers for Disease Control and Prevention has issued updated advice on the COVID-19 vaccine days after Health and Human Services Secretary Robert F. Kennedy Jr said the agency would no longer recommend the shot to children and pregnant women.
The agency has kept the shot on its vaccine schedule for children between the ages of 6 months to 17 years of age, despite Kennedy saying they would no longer be recommended.
The CDC says children with no underlying health condition 'may receive' COVID-19 vaccines, instead of broadly recommending that all children should get the inoculation. It now advises 'shared clinical decision-making' between parents and physicians.
'Where the parent presents with a desire for their child to be vaccinated, children 6 months and older may receive COVID-19 vaccination, informed by the clinical judgment of a healthcare provider and personal preference and circumstances,' the guidelines now say.
The changes to the CDC's recommendations for children mean that health insurance companies are still ostensibly required to cover the shot, at least for now.
However, there is a history of some health insurance companies not covering drugs listed on 'shared clinical decision-making' recommendations, healthcare lawyer Richard Hughes IV said in an email.
'Based on my collective observations of payer coverage of vaccines, the bottom line is expect variability in coverage, prior authorization and out-of-pocket, all of which will discourage uptake.'
Kennedy said Tuesday the CDC would no longer recommend routine COVID-19 shots for healthy children and pregnant women in a post on the social media platform X.
'Last year, the Biden administration urged healthy children to get yet another COVID shot, despite the lack of any clinical data to support the repeat booster strategy in children,' Kennedy said in a video, joined by Food and Drug Administration (FDA) Commissioner Marty Makary and National Institutes of Health (NIH) Director Jay Bhattacharya.
'It's common sense, and it's good science,' Bhattacharya said of the change.
It's unclear how COVID-19 vaccine guidelines will change for pregnant women. The CDC's stance on COVID-19 vaccines during pregnancy is now 'no guidance,' per a memo released from the agency Friday, according to The New York Times. The vaccine was previously recommended for all pregnant people.
The CDC's website also continues to host pages of guidance recommending that pregnant women continue to receive the COVID-19 vaccine because of the higher risk they have of developing serious illness from the disease.
'Studies including hundreds of thousands of people around the world show that COVID-19 vaccination before and during pregnancy is safe, effective, and beneficial to both the pregnant woman and the baby,' the website states.
The Department of Health and Human Services has yet to respond to questions about the new guidelines from The Hill.
Nathaniel Weixel contributed to this report.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Marjorie Taylor Greene Fumes Over Vaccine Approval: 'Not MAHA at All'
Marjorie Taylor Greene Fumes Over Vaccine Approval: 'Not MAHA at All'

Newsweek

timean hour ago

  • Newsweek

Marjorie Taylor Greene Fumes Over Vaccine Approval: 'Not MAHA at All'

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Marjorie Taylor Greene has spoken out against a new COVID-19 vaccine being approved in the United States, saying the move is "not MAHA at all." Why It Matters Health Secretary Robert F. Kennedy Jr. is facing repeated backlash for some of his positions on health and medicine, including from people who would ordinarily support him. In May, prominent members of the Make America Great Again movement, including Nicole Shanahan, Kennedy's former presidential running mate, and media personality Laura Loomer, spoke out against Kennedy Jr.'s pick for U.S. Surgeon General Casey Means. In March, Kennedy Jr. sparked anger from anti-vax activists when he called on parents to "consult with their healthcare providers to understand their options to get the MMR vaccine," with one saying he is "no different than Fauci." Marjorie Taylor Greene, R-Ga., arrives for a meeting of House Republicans in the Capitol Visitor Center on May 15, 2025. Marjorie Taylor Greene, R-Ga., arrives for a meeting of House Republicans in the Capitol Visitor Center on May 15, 2025. AP What To Know The U.S. Food and Drug Administration (FDA) gave the green light for mNEXSPIKE (mRNA-1283), Moderna's new lower-dose COVID-19 vaccine, on May 31. Greene, the U.S. representative for Georgia's 14th congressional district, shared Moderna's post about the recent approval with the caption: "Not MAHA at all!!! Unreal." Not MAHA at all!!! Unreal. — Rep. Marjorie Taylor Greene🇺🇸 (@RepMTG) June 1, 2025 She was referring to Kennedy Jr.'s movement Make America Healthy Again, whose mission is to "aggressively combat the critical health challenges facing our citizens, including the rising rates of mental health disorders, obesity, diabetes, and other chronic diseases." Newsweek has contacted the United States Department of Health and Human Services outside of office hours, via email, for comment. The new vaccine is set to be used for adults 65 or older or people between the ages of 12 and 64 with at least one or more underlying risk factor as defined by the Centers for Disease Control and Prevention (CDC). Approval for the jab is "based on results from a randomized, observer-blind, active-controlled Phase 3 clinical trial which enrolled approximately 11,400 participants aged 12 years and older," Moderna says. It comes after Kennedy Jr. announced that the CDC is no longer encouraging COVID-19 vaccines for pregnant women and healthy children, marking a shift in federal public health guidance. What People Are Saying Chief Executive Officer of Moderna Stéphane Bancel said in a statement: "The FDA approval of our third product, mNEXSPIKE, adds an important new tool to help protect people at high risk of severe disease from COVID-19. "COVID-19 remains a serious public health threat, with more than 47,000 Americans dying from the virus last year alone. We appreciate the FDA's timely review and thank the entire Moderna team for their hard work and continued commitment to public health." Kennedy Jr. said about the new CDC guidance: "I couldn't be more pleased to announce that as of today the COVID vaccine for healthy children and healthy pregnant women has been removed from the CDC recommended immunization schedule." What Happens Next The new vaccine is expected to be ready for those eligible to take it in time for the 2025-2026 respiratory virus season. You should not get mNEXSPIKE if you had a severe allergic reaction after a previous dose of either mNEXSPIKE, SPIKEVAX (an mRNA vaccine for preventing COVID-19) or any Moderna COVID-19 vaccine or to any ingredient in these vaccines, the company warns.

Moderna announces FDA approved mNEXSPIKE, new vaccine against COVID-19
Moderna announces FDA approved mNEXSPIKE, new vaccine against COVID-19

Business Insider

time3 hours ago

  • Business Insider

Moderna announces FDA approved mNEXSPIKE, new vaccine against COVID-19

Moderna (MRNA) announced that the U.S. Food and Drug Administration, FDA, has approved mNEXSPIKE, a new vaccine against COVID-19, for use in all adults 65 and older, as well as individuals aged 12-64 years with at least one or more underlying risk factor as defined by the Centers for Disease Control and Prevention. 'The FDA approval of our third product, mNEXSPIKE, adds an important new tool to help protect people at high risk of severe disease from COVID-19,' said Stephane Bancel, Chief Executive Officer of Moderna. 'COVID-19 remains a serious public health threat, with more than 47,000 Americans dying from the virus last year alone. We appreciate the FDA's timely review and thank the entire Moderna team for their hard work and continued commitment to public health.' Confident Investing Starts Here:

COVID Variant That's Been Circulating Since 2024 Still Dominant Strain in US: CDC
COVID Variant That's Been Circulating Since 2024 Still Dominant Strain in US: CDC

Epoch Times

time7 hours ago

  • Epoch Times

COVID Variant That's Been Circulating Since 2024 Still Dominant Strain in US: CDC

Recent data published by the U.S. Centers for Disease Control and Prevention (CDC) shows that a COVID-19 variant that has been circulating since last year is currently the dominant variant in the United States. The LP.8.1 COVID-19 variant, an offshoot of the Omicron strain, was first detected in June 2024, health officials have said. CDC data show that it makes up 73 percent of all cases detected in the country as of May 24, according to an update issued on June 1. The XFC variant is No. 2 at 10 percent, and the XEC variant is third at 4 percent.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store